IL148615A0 - Genetic markers of toxicity, preparation and uses thereof - Google Patents

Genetic markers of toxicity, preparation and uses thereof

Info

Publication number
IL148615A0
IL148615A0 IL14861500A IL14861500A IL148615A0 IL 148615 A0 IL148615 A0 IL 148615A0 IL 14861500 A IL14861500 A IL 14861500A IL 14861500 A IL14861500 A IL 14861500A IL 148615 A0 IL148615 A0 IL 148615A0
Authority
IL
Israel
Prior art keywords
toxicity
methods
genetic markers
compounds
nucleic acid
Prior art date
Application number
IL14861500A
Other languages
English (en)
Original Assignee
Exonhit Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exonhit Therapeutics Sa filed Critical Exonhit Therapeutics Sa
Publication of IL148615A0 publication Critical patent/IL148615A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14861500A 1999-09-13 2000-09-12 Genetic markers of toxicity, preparation and uses thereof IL148615A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911405A FR2798392B1 (fr) 1999-09-13 1999-09-13 Marqueurs genetiques de la toxicite, preparation et utilisations
PCT/FR2000/002503 WO2001020029A2 (fr) 1999-09-13 2000-09-12 Marquers genetiques de la toxicite, preparation et utilisations

Publications (1)

Publication Number Publication Date
IL148615A0 true IL148615A0 (en) 2002-09-12

Family

ID=9549766

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14861500A IL148615A0 (en) 1999-09-13 2000-09-12 Genetic markers of toxicity, preparation and uses thereof

Country Status (13)

Country Link
US (2) US6509153B1 (enExample)
EP (1) EP1220950B9 (enExample)
JP (1) JP2003509066A (enExample)
AT (1) ATE263255T1 (enExample)
AU (1) AU783310B2 (enExample)
CA (1) CA2380383A1 (enExample)
DE (1) DE60009530T2 (enExample)
DK (1) DK1220950T3 (enExample)
ES (1) ES2216958T3 (enExample)
FR (1) FR2798392B1 (enExample)
IL (1) IL148615A0 (enExample)
PT (1) PT1220950E (enExample)
WO (1) WO2001020029A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US7361488B2 (en) * 2000-02-07 2008-04-22 Illumina, Inc. Nucleic acid detection methods using universal priming
DE60236559D1 (de) * 2001-08-24 2010-07-08 Daikin Ind Ltd Verfahren zum Nachweis toxischer Substanzen
GB0410105D0 (en) * 2004-05-06 2004-06-09 Amersham Biosciences Uk Ltd Method for characterising compounds
US20080194417A1 (en) * 2005-03-09 2008-08-14 Luca Barella Method for Measuring and Comparing the Activity of Biologically Active Compounds
CN101611315A (zh) * 2006-10-23 2009-12-23 Uab研究基金会 用于对抗癌试剂敏感的癌症的生物标记物及其用途
DE102010024898B4 (de) * 2010-06-24 2012-10-25 Merck Patent Gmbh Genexpressionsanalysen zur Charakterisierung und Identifizierung genotoxischer Verbindungen

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5985549A (en) * 1985-10-22 1999-11-16 University Of Massachusetts Non-isotopic in-situ hybridization method for detection of nucleic acids
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6309822B1 (en) * 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
US5521297A (en) * 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5529925A (en) * 1993-12-03 1996-06-25 St. Jude Children's Research Hospital Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US5484702A (en) * 1994-01-27 1996-01-16 Research Foundation Of The State University Of New York At Buffalo Method for preselecting recombinant clones containing a specific nucleic acid sequence and subsequent transformation with preselected clones
US5679541A (en) * 1994-02-14 1997-10-21 California Institute Of Technology Programmed cell death antagonist protein
PH31414A (en) * 1994-02-24 1998-10-29 Boehringer Ingelheim Int Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
US5767258A (en) * 1995-05-12 1998-06-16 The Johns Hopkins University School Of Medicine Cell cycle regulatory gene
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US5922535A (en) * 1995-11-07 1999-07-13 Huo; Li Identifying sequence differences in nucleic acid populations
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2755984B1 (fr) * 1996-11-15 2002-12-27 Bourachot Philippe Borne escamotable
US6060240A (en) * 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
CA2225187A1 (en) * 1997-07-14 1999-01-14 Universite D'ottawa/ University Of Ottawa Xaf genes and polypeptides: methods and reagents for modulating apoptosis
US6849400B1 (en) * 1997-07-23 2005-02-01 Gen-Probe Incorporated Methods for detecting and measuring spliced nucleic acids
GB9717766D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Methods
US6432640B1 (en) * 1997-09-17 2002-08-13 The Johns Hopkins University P53-induced apoptosis
DE69925362T2 (de) * 1998-02-23 2006-01-19 Phylonix Pharmaceuticals Inc., Cambridge Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
JPH11262621A (ja) * 1998-03-17 1999-09-28 Ebara Corp 除湿空調装置
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
WO2000012760A2 (en) * 1998-08-28 2000-03-09 Incyte Pharmaceuticals, Inc. Toxicological response markers
US6160105A (en) * 1998-10-13 2000-12-12 Incyte Pharmaceuticals, Inc. Monitoring toxicological responses
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
EP1654371A4 (en) * 2001-06-21 2010-02-10 Verenium Corp METHOD FOR PRODUCING PURE ENANTIOMERIC PURELY COMPOUNDS AND SELECTION OF ENANTIOSELECTIVE ENZYMES

Also Published As

Publication number Publication date
EP1220950B9 (fr) 2004-11-03
ATE263255T1 (de) 2004-04-15
AU783310B2 (en) 2005-10-13
ES2216958T3 (es) 2004-11-01
US20030059788A1 (en) 2003-03-27
US6509153B1 (en) 2003-01-21
EP1220950B1 (fr) 2004-03-31
WO2001020029A3 (fr) 2001-11-29
JP2003509066A (ja) 2003-03-11
AU7426900A (en) 2001-04-17
PT1220950E (pt) 2004-07-30
FR2798392A1 (fr) 2001-03-16
DE60009530T2 (de) 2005-02-03
WO2001020029A2 (fr) 2001-03-22
DE60009530D1 (de) 2004-05-06
FR2798392B1 (fr) 2005-07-15
CA2380383A1 (fr) 2001-03-22
DK1220950T3 (da) 2004-08-02
EP1220950A2 (fr) 2002-07-10

Similar Documents

Publication Publication Date Title
Murphy et al. Association of high-molecular-weight proteins with microtubules and their role in microtubule assembly in vitro.
Lin et al. Fast kinetic study of yeast phenylalanyl-tRNA synthetase: role of tRNAPhe in the discrimination between tyrosine and phenylalanine
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
WO2004048598A3 (en) Molecular nephrotoxicology modeling
WO2002010453A3 (en) Molecular toxicology modeling
WO2006117596A3 (en) Nucleic acid probes and nucleic acid analog probes
ATE480643T1 (de) Homogener nachweis von analyten
WO2002095000A8 (en) Molecular toxicology modeling
Gibson et al. Requirement for bicarbonate in fatty acid synthesis1
AU2001268449A1 (en) Toxicity typing using liver stem cells
WO2004063334A8 (en) Molecular cardiotoxicology modeling
DE60128404D1 (de) Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker
IL148615A0 (en) Genetic markers of toxicity, preparation and uses thereof
GB2430740A (en) System and method for tracking and quatitating chemical entites
WO2003064624A3 (en) Molecular hepatotoxicology modeling
Liu et al. Analysis of poly (ADP-ribose) polymerase-1 by enzyme-initiated auto-PARylation-controlled aggregation of hemin-graphene nanocomposites
Heidary et al. A light‐activated metal complex targets both DNA and RNA in a fluorescent in vitro transcription and translation assay
TW200506067A (en) Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence
Meyer et al. RNA synthesis by isolated mammalian mitochondria and nuclei: effects of ethidium bromide and acriflavin
Huang et al. Kinetic analysis of PI3K reactions with fluorescent PIP2 derivatives
ES2185002T3 (es) Metodos y composiciones para detectar mutaciones por empalme de la deshidrogenasa de dihidro-pirimidina.
AU3775099A (en) Methods, kits and compositions for detecting and quantitating target sequences
Zhang et al. A sensitive assay of telomerase activity based on the controllable aggregation of quantum dots
WO2003068908A8 (en) Cardiotoxin molecular toxicology modeling
BR9708256A (pt) Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo